News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Ordentlich Peter
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2022 |
4
| Ordentlich Peter (Chief Scientific Officer) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 3,772 shares
@ $25.0114, valued at
$94.3k
Sold 4,028 shares
@ $25.0114, valued at
$100.7k
Sold 17,200 shares
@ $25.0544, valued at
$430.9k
Exercised 4,028 options to buy
@ $6.38, valued at
$25.7k
Exercised 3,772 options to buy
@ $6.35, valued at
$24k
Exercised 17,200 options to buy
@ $6.38, valued at
$109.7k
|
|
| 08/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/25/2020 |
4
| Ordentlich Peter (Chief Scientific Officer) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 5,684 shares
@ $23.3291, valued at
$132.6k
Sold 7,954 shares
@ $23.5849, valued at
$187.6k
Sold 16,334 shares
@ $22.8924, valued at
$373.9k
Exercised 24,288 options to buy
@ $3.08, valued at
$74.8k
Exercised 5,684 options to buy
@ $3.08, valued at
$17.5k
|
|
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2018 |
4
| Ordentlich Peter (Chief Scientific Officer) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Sold 7,500 shares
@ $15, valued at
$112.5k
Exercised 7,500 options to buy
@ $3.08, valued at
$23.1k
|
|
| 03/05/2018 |
4
| Ordentlich Peter (Chief Scientific Officer) has filed a Form 4 on Syndax Pharmaceuticals Inc|
Txns:
| Granted 40,000 options to buy
@ $9.4, valued at
$376k
|
|
| 05/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|